574 related articles for article (PubMed ID: 18786162)
21. Absence of association of alpha1-antichymotrypsin polymorphisms with Alzheimer's disease: a report on autopsy-confirmed cases.
Itabashi S; Arai H; Matsui T; Matsushita S; Muramatsu T; Higuchi S; Trojanowski JQ; Sasaki H
Exp Neurol; 1998 Jun; 151(2):237-40. PubMed ID: 9628759
[TBL] [Abstract][Full Text] [Related]
22. Polymorphism at codon 66 of the brain-derived neurotrophic factor gene is not associated with sporadic Alzheimer's disease.
Combarros O; Infante J; Llorca J; Berciano J
Dement Geriatr Cogn Disord; 2004; 18(1):55-8. PubMed ID: 15084795
[TBL] [Abstract][Full Text] [Related]
23. Variations in the BDNF gene in autopsy-confirmed Alzheimer's disease and dementia with Lewy bodies in Japan.
Akatsu H; Yamagata HD; Kawamata J; Kamino K; Takeda M; Yamamoto T; Miki T; Tooyama I; Shimohama S; Kosaka K
Dement Geriatr Cogn Disord; 2006; 22(3):216-22. PubMed ID: 16899999
[TBL] [Abstract][Full Text] [Related]
24. Brain-derived neurotrophic factor polymorphism Val66Met influences cognitive abilities in the elderly.
Miyajima F; Ollier W; Mayes A; Jackson A; Thacker N; Rabbitt P; Pendleton N; Horan M; Payton A
Genes Brain Behav; 2008 Jun; 7(4):411-7. PubMed ID: 17973920
[TBL] [Abstract][Full Text] [Related]
25. Lack of neural compensatory mechanisms of BDNF val66met met carriers and APOE E4 carriers in healthy aging, mild cognitive impairment, and Alzheimer's disease.
Gomar JJ; Conejero-Goldberg C; Huey ED; Davies P; Goldberg TE;
Neurobiol Aging; 2016 Mar; 39():165-73. PubMed ID: 26923413
[TBL] [Abstract][Full Text] [Related]
26. APOE and modulation of Alzheimer's and frontotemporal dementia.
Boccardi M; Sabattoli F; Testa C; Beltramello A; Soininen H; Frisoni GB
Neurosci Lett; 2004 Feb; 356(3):167-70. PubMed ID: 15036621
[TBL] [Abstract][Full Text] [Related]
27. Brain-derived neurotrophic factor gene polymorphisms in Japanese patients with sporadic Alzheimer's disease, Parkinson's disease, and multiple system atrophy.
Nishimura M; Kuno S; Kaji R; Kawakami H
Mov Disord; 2005 Aug; 20(8):1031-3. PubMed ID: 15838855
[TBL] [Abstract][Full Text] [Related]
28. The relation of regional cerebral perfusion and atrophy in mild cognitive impairment (MCI) and early Alzheimer's dementia.
Luckhaus C; Cohnen M; Flüss MO; Jänner M; Grass-Kapanke B; Teipel SJ; Grothe M; Hampel H; Peters O; Kornhuber J; Maier W; Supprian T; Gaebel W; Mödder U; Wittsack HJ
Psychiatry Res; 2010 Jul; 183(1):44-51. PubMed ID: 20541374
[TBL] [Abstract][Full Text] [Related]
29. Reduced hippocampal volume in non-demented carriers of the apolipoprotein E epsilon4: relation to chronological age and recognition memory.
Lind J; Larsson A; Persson J; Ingvar M; Nilsson LG; Bäckman L; Adolfsson R; Cruts M; Sleegers K; Van Broeckhoven C; Nyberg L
Neurosci Lett; 2006 Mar; 396(1):23-7. PubMed ID: 16406347
[TBL] [Abstract][Full Text] [Related]
30. [Study of relationship between ApoE epsilon4 allele and hippocampal atrophy in Alzheimer disease].
Li J; Kuang WH; Li J; Wang X; Huang MS; Wu DP
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Jan; 36(1):50-2. PubMed ID: 15702779
[TBL] [Abstract][Full Text] [Related]
31. Genetic variation in apolipoprotein E alters regional gray matter volumes in remitted late-onset depression.
Yuan Y; Zhang Z; Bai F; You J; Yu H; Shi Y; Liu W
J Affect Disord; 2010 Mar; 121(3):273-7. PubMed ID: 19647324
[TBL] [Abstract][Full Text] [Related]
32. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
Susanto TA; Pua EP; Zhou J;
J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
[TBL] [Abstract][Full Text] [Related]
33. EEG functional connectivity and ApoE genotype in Alzheimer's disease and controls.
Kramer G; van der Flier WM; de Langen C; Blankenstein MA; Scheltens P; Stam CJ
Clin Neurophysiol; 2008 Dec; 119(12):2727-32. PubMed ID: 18848805
[TBL] [Abstract][Full Text] [Related]
34. BDNF genetic variations increase the risk of Alzheimer's disease-related depression.
Borroni B; Grassi M; Archetti S; Costanzi C; Bianchi M; Caimi L; Caltagirone C; Di Luca M; Padovani A
J Alzheimers Dis; 2009; 18(4):867-75. PubMed ID: 19661618
[TBL] [Abstract][Full Text] [Related]
35. Four subgroups of Alzheimer's disease based on patterns of atrophy using VBM and a unique pattern for early onset disease.
Shiino A; Watanabe T; Maeda K; Kotani E; Akiguchi I; Matsuda M
Neuroimage; 2006 Oct; 33(1):17-26. PubMed ID: 16904912
[TBL] [Abstract][Full Text] [Related]
36. Effects of brain-derived neurotrophic factor Val66Met polymorphism on hippocampal volume change in schizophrenia.
Koolschijn PC; van Haren NE; Bakker SC; Hoogendoorn ML; Hulshoff Pol HE; Kahn RS
Hippocampus; 2010 Sep; 20(9):1010-7. PubMed ID: 19714565
[TBL] [Abstract][Full Text] [Related]
37. Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression.
Frodl T; Schüle C; Schmitt G; Born C; Baghai T; Zill P; Bottlender R; Rupprecht R; Bondy B; Reiser M; Möller HJ; Meisenzahl EM
Arch Gen Psychiatry; 2007 Apr; 64(4):410-6. PubMed ID: 17404118
[TBL] [Abstract][Full Text] [Related]
38. Risk of late-onset Alzheimer's disease associated with BDNF C270T polymorphism.
Olin D; MacMurray J; Comings DE
Neurosci Lett; 2005 Jun; 381(3):275-8. PubMed ID: 15896483
[TBL] [Abstract][Full Text] [Related]
39. Apolipoprotein E epsilon4 is associated with atrophy of the amygdala in Alzheimer's disease.
Basso M; Gelernter J; Yang J; MacAvoy MG; Varma P; Bronen RA; van Dyck CH
Neurobiol Aging; 2006 Oct; 27(10):1416-24. PubMed ID: 16182410
[TBL] [Abstract][Full Text] [Related]
40. Effect of brain-derived neurotrophic factor Val66Met polymorphism and serum levels on the progression of mild cognitive impairment.
Forlenza OV; Diniz BS; Teixeira AL; Ojopi EB; Talib LL; Mendonça VA; Izzo G; Gattaz WF
World J Biol Psychiatry; 2010 Sep; 11(6):774-80. PubMed ID: 20491609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
